Coverage
-
March 18, 2020
A federal jury in Delaware cleared Oxford Nanopore Technologies Inc. on Wednesday of claims that some of its DNA analysis technology and devices — used in early coronavirus investigations in China — infringed four patents held by Pacific Biosciences of California Inc.
3 other articles on this case.
View all »